Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II trial of intracoronary autologous bone marrow mononuclear cells in chronic anterior myocardial infarction with severe left ventricular dysfunction
2009-016599-66Phase 2Active
- Sponsor
- Andalusian Progress and Health Public Foundation
- Start
- Apr 2010
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of autologous bone marrow-derived mononuclear cell in myocardial infarction (MI) and heart failure (HF), sponsored by Andalusian Progress and Health Public Foundation. Primary endpoints: Improvement in ventricular function during follow-up, Hemodynamic measures of ventricular function and 2 more. Started Apr 2010; status: active.
02
Drugs
autologous bone marrow-derived mononuclear cell
03
Conditions
myocardial infarction (MI)heart failure (HF)
Beyond the preview
Go deeper on 2009-016599-66.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-016599-66.